Gary Mok

814 total citations
17 papers, 239 citations indexed

About

Gary Mok is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Molecular Biology. According to data from OpenAlex, Gary Mok has authored 17 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiation and 5 papers in Molecular Biology. Recurrent topics in Gary Mok's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (7 papers) and Advanced Radiotherapy Techniques (6 papers). Gary Mok is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (7 papers) and Advanced Radiotherapy Techniques (6 papers). Gary Mok collaborates with scholars based in Canada, Hong Kong and China. Gary Mok's co-authors include Raymond Miralbell, Jean‐Paul Vallée, Thomas Zilli, Padraig Warde, Brian Hon‐Yin Chung, Anthony P. Y. Liu, Kelvin Y.K. Chan, Wanling Yang, Tom Pickles and Éric Vigneault and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Gary Mok

16 papers receiving 234 citations

Peers

Gary Mok

PRM

RADIA

SURGE

GENET

B. Laser United States

É. Costa France

Brock R. Baker United States

Gregory Vlacich United States

E. Fernández-Velilla Spain

R. Allerton United Kingdom

J. Quera Spain

Helen Benghiat United Kingdom

Kelly Underhill United States

B. Laser United States

Gary Mok

232 ×1.6

PRM

120 ×1.5

RADIA

33 ×0.6

SURGE

33 ×0.7

17 ×0.4

GENET

Citations per year, relative to Gary Mok Gary Mok (= 1×) peers B. Laser

Countries citing papers authored by Gary Mok

Since Specialization

Citations

This map shows the geographic impact of Gary Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Mok more than expected).

Fields of papers citing papers by Gary Mok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Mok. The network helps show where Gary Mok may publish in the future.

Co-authorship network of co-authors of Gary Mok

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Mok. A scholar is included among the top collaborators of Gary Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Mok. Gary Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Saad, Fred, Claire Petit, Guila Delouya, et al.. (2025). Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy. JAMA Oncology. 11(12). 1431–1431.

Saad, Fred, Claire Petit, Guila Delouya, et al.. (2024). Randomized Controlled Trial of PSMA-PET Image Guided Intensification of Salvage Radiotherapy after Radical Prostatectomy: Which Patients Are Most Likely to Benefit and Other Secondary Analyses. International Journal of Radiation Oncology*Biology*Physics. 120(2). S56–S57. 1 indexed citations

Petit, Claire, Guila Delouya, Daniel Taussky, et al.. (2023). PSMA-PET/CT-Guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): Findings of Detection Rate, Effect on Cancer Management, and Early Toxicity From a Phase 2 Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. 116(4). 779–787. 8 indexed citations

Mok, Gary, Kit San Yeung, Wanling Yang, et al.. (2018). Exome sequencing for paediatric-onset diseases: impact of the extensive involvement of medical geneticists in the diagnostic odyssey. npj Genomic Medicine. 3(1). 19–19. 8 indexed citations

Mak, Christopher Chun Yu, Jasmine Lee Fong Fung, Wilfred Hing Sang Wong, et al.. (2018). Identifying the genetic causes for prenatally diagnosed structural congenital anomalies (SCAs) by whole-exome sequencing (WES). BMC Medical Genomics. 11(1). 93–93. 34 indexed citations

McPartlin, Andrew, Rachel Glicksman, Melania Pintilie, et al.. (2016). PMH 9907: Long‐term outcomes of a randomized phase 3 study of short‐term bicalutamide hormone therapy and dose‐escalated external‐beam radiation therapy for localized prostate cancer. Cancer. 122(16). 2595–2603. 12 indexed citations

Mak, Christopher Chun Yu, Pak‐cheong Chow, Anthony P. Y. Liu, et al.. (2016). De novo large rare copy-number variations contribute to conotruncal heart disease in Chinese patients. npj Genomic Medicine. 1(1). 16033–16033. 7 indexed citations

Chiu, Annie Ting Gee, et al.. (2016). Before and after – Nutritional transformation of dysmorphism in a case of Costello syndrome. European Journal of Medical Genetics. 59(11). 573–576. 4 indexed citations

Liu, Anthony P. Y., Pak‐cheong Chow, Pamela Lee, et al.. (2014). Under-recognition of 22q11.2 deletion in adult Chinese patients with conotruncal anomalies: Implications in transitional care. European Journal of Medical Genetics. 57(6). 306–311. 23 indexed citations

10.

Rodrigues, George, Himu Lukka, Padraig Warde, et al.. (2014). The Prostate Cancer Risk Stratification Project: Database Construction and Risk Stratification Outcome Analysis. Journal of the National Comprehensive Cancer Network. 12(1). 60–69. 10 indexed citations

11.

Mok, Gary, et al.. (2014). Optimization of Radiation Therapy Techniques for Prostate Cancer With Prostate-Rectum Spacers: A Systematic Review. International Journal of Radiation Oncology*Biology*Physics. 90(2). 278–288. 62 indexed citations

12.

Mok, Gary, Isabelle Gauthier, Haiyan Jiang, et al.. (2014). Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer. Head & Neck. 37(5). 655–661. 31 indexed citations

13.

Rodrigues, George, Himu Lukka, Padraig Warde, et al.. (2013). The prostate cancer risk stratification (ProCaRS) project: Recursive partitioning risk stratification analysis. Radiotherapy and Oncology. 109(2). 204–210. 27 indexed citations

14.

Mok, Gary, Rachel Glicksman, Jenna Sykes, et al.. (2012). OC-0046 SHORT TERM HORMONE THERAPY AND DOSE ESCALATED RADIATION FOR LOCALIZED PROSTATE CANCER: A RANDOMIZED PHASE III STUDY. Radiotherapy and Oncology. 103. S18–S18. 2 indexed citations

15.

Rodrigues, George, Himu Lukka, Padraig Warde, et al.. (2012). The Prostate Cancer Risk Stratification (ProCaRS) Project: Recursive Partitioning Risk Stratification Analysis. International Journal of Radiation Oncology*Biology*Physics. 84(3). S181–S182. 3 indexed citations

16.

Mok, Gary & Padraig Warde. (2011). Management of Stage I Testicular Seminoma. Hematology/Oncology Clinics of North America. 25(3). 503–516. 6 indexed citations

17.

Mok, Gary, Jarad Martin, Cynthia Ménard, et al.. (2011). A Comparison of Conventional and Hypofractionated Radiotherapy Schedules In the Treatment of Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 81(2). S401–S402. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact